From: Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma
IgG < 665
NAC regimen, n (%)
 FP
4 (9%)
 DCF
6 (19%)
NAC cycles, n (%)
 1
3 (13%)
 2
7 (13%)